The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
The ABPI is a strong advocate for transparency in clinical trial information.
The ABPI supports research using animals where alternative methods are not available, where the potential benefits to health are compelling, and where acceptable ethical and welfare standards can be met.
By working with patient organisations we can ensure that we are developing and delivering medicines which can make the most impact on people's health and wellbeing.
Our member companies seek to operate in an ethically-responsible manner, leading the way in developing innovative approaches to improving and increasing length and quality of life, whilst also considering global developing world and environmental issues.
In June 2017, the European Federation of Pharmaceutical Industries and Associations (EFPIA) with support from the ABPI in the UK, launched #WeWontRest.